Clinical Trials
10 trialsNCT02065687 2021-09-30
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
GOG Foundation
Phase 2/3 Unknown
NCT01642082 2018-03-13
Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer
GOG Foundation
Phase 2 Completed
NCT00820898 2017-12-29
Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
GOG Foundation
Phase 2 Completed
NCT00888173 2017-12-06
Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer
GOG Foundation
Phase 2 Completed
NCT01225887 2017-10-09
Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer
GOG Foundation
Phase 2 Completed
NCT01208467 2017-08-23
Prognostic Biomarkers in Patients With Endometrial Cancer
GOG Foundation
Completed
NCT00064025 2016-04-11
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
GOG Foundation
Phase 2 Completed
NCT00002706 2015-05-29
Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
GOG Foundation
Phase 3 Completed
NCT00006011 2015-05-19
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
GOG Foundation
Phase 3 Completed
NCT00005830 2014-12-31
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
GOG Foundation
Phase 1 Completed